Roche says it has signed an agreement to sell worldwide rights of four of its pharmaceutical products to specialty pharma company Meda (Solna, Sweden) for a total of €120 million ($176 million). The transaction is expected to close by year-end. The...
This information is only available to Chemical Week 24/7 members and subscribers.
Forgot your user ID or password? Click here to have it sent to you.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers